文献速递神经免疫

神经科医生与产业界的财务关系:2015年开放支付数据库分析

Financial relationships between neurologists and industry: The 2015 Open Payments database.
PubMed 文献 · Neurology · 2018-05-04

该回顾性数据库分析利用2015年CMS开放支付数据库,分析了美国神经科医生从制药和器械产业获得的科研与非科研支付。约51%的美国神经科医生获得非科研支付共6,210,414美元,中位支付81美元;412名神经科医生获得科研支付共2,921,611美元,中位1,132美元。作者认为开放支付项目效果尚不明确,需进一步研究。

要点

  • 2015年约51%美国神经科医生获得非科研支付共6,210,414美元,中位81美元。
  • 非科研支付前10%的神经科医生获得5,278,852美元(84.5%)。
  • 412名神经科医生获得科研支付共2,921,611美元,中位1,132美元。

核心结论

  • 开放支付项目旨在回应立法和公众对利益冲突影响实践、教育和研究的担忧,促进产业补偿的透明披露。
  • 该项目的效果仍不明确,有必要研究处方行为、费用和其他结局的变化。
  • CMS应确保错误信息能够快速简便地得到纠正。

研究设计与样本

  • 回顾性数据库分析。
  • 使用2015年CMS开放支付数据库分析美国神经科医生从制药和器械产业获得的科研与非科研支付。
  • 从2015年AAMC州医师劳动力数据手册计算执业神经科医生人数。

主要发现

  • 2015年约51%的美国神经科医生获得非科研支付,总额6,210,414美元,中位支付81美元。
  • 非科研支付中前10%的神经科医生获得5,278,852美元(84.5%)。
  • 食品和饮料是最常见的支付类别(占总支付笔数的86.5%)。
  • 非科研支付金额最高的类别为担任非继续医学教育活动的教员/讲者(58%)。
  • 非科研支付的最大赞助方为Teva Pharmaceuticals(1,162,900美元;18.5%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze research and nonresearch payments from the pharmaceutical and device industry to neurologists in 2015 using the Centers for Medicare and Medicaid Services (CMS) Open Payments database. METHODS: In this retrospective database analysis, we computed the percentage of neurologists in the United States receiving payments, the median/mean payments per neurologist, payment categories, regional trends, and sponsors. We computed the number of practicing neurologists from the Association of American Medical Colleges State Physician Workforce data book, 2015. RESULTS: In 2015, approximately 51% of US neurologists received nonresearch payments totaling $6,210,414. The median payment per physician was $81. Payments to the top 10% of compensated neurologists amounted to $5,278,852 (84.5%). Food and beverage was the most frequent category (86.5% of the total number of payments). The highest amount was paid for serving as faculty/speaker for noncontinuing medical education activities (58%). The top sponsor of nonresearch payments was Teva Pharmaceuticals ($1,162,900; 18.5%). A total of 412 neurologists received $2,921,611 in research payments (median $1,132). Multiple sclerosis specialists received the largest proportion ($285,537; 9.7%). Daiichi Sankyo paid the largest amount in research payments ($826,029; 28%). CONCLUSIONS: The Open Payments program was established to foster transparent disclosure of physician compensation from industry, in response to legislative and public concerns over the effect of conflicts of interest on practice, education, and research. The effects of this program remain unclear and studies of changes in prescribing practices, costs, and other outcomes are necessary. CMS should ensure that incorrect information can be rectified quickly and easily.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ahlawat A, Narayanaswami P. Financial relationships between neurologists and industry: The 2015 Open Payments database. Neurology. 2018. PMID: 29728521. doi:10.1212/WNL.0000000000005657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。